(Q28507667)

24 January 2017

title

Mekk3 is essential for early embryonic cardiovascular development (English)

1 reference

Mitogen-activated protein kinase kinase kinase 3

24 January 2017

main subject

1 reference

GOA release 2020-03-11

1 reference

J. Yang

1

1 reference

24 January 2017

M. Boerm

2

1 reference

24 January 2017

M. McCarty

3

1 reference

24 January 2017

C. Bucana

4

1 reference

24 January 2017

I. J. Fidler

5

1 reference

24 January 2017

Y. Zhuang

6

1 reference

24 January 2017

B. Su

7

1 reference

24 January 2017

language of work or name

English

0 references

publication date

1 March 2000

1 reference

24 January 2017

1 reference

24 January 2017

volume

24

1 reference

24 January 2017

issue

3

1 reference

24 January 2017

page(s)

309–313

1 reference

Molecular cloning of mitogen-activated protein/ERK kinase kinases (MEKK) 2 and 3. Regulation of sequential phosphorylation pathways involving mitogen-activated protein kinase and c-Jun kinase

24 January 2017

cites work

1 reference

Direct activation of the stress-activated protein kinase (SAPK) and extracellular signal-regulated protein kinase (ERK) pathways by an inducible mitogen-activated protein Kinase/ERK kinase kinase 3 (MEKK) derivative

21 April 2017

1 reference

Characterization of the mitogen-activated protein kinase kinase 4 (MKK4)/c-Jun NH2-terminal kinase 1 and MKK3/p38 pathways regulated by MEK kinases 2 and 3. MEK kinase 3 activates MKK3 but does not cause activation of p38 kinase in vivo

21 April 2017

1 reference

MEK kinase 3 directly activates MKK6 and MKK7, specific activators of the p38 and c-Jun NH2-terminal kinases

21 April 2017

1 reference

Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium

21 April 2017

1 reference

Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice

21 April 2017

1 reference

Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis

21 April 2017

1 reference

Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation

21 April 2017

1 reference

Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis

21 April 2017

1 reference

Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C

21 April 2017

1 reference

The transcription factor MEF2C-null mouse exhibits complex vascular malformations and reduced cardiac expression of angiopoietin 1 and VEGF

21 April 2017

1 reference

Molecular cloning and characterization of a human protein kinase that specifically activates c-Jun N-terminal kinase

21 April 2017

1 reference

Mechanisms of angiogenesis

21 April 2017

1 reference

Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele

21 April 2017

1 reference

Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene

21 April 2017

1 reference

Blood vessel formation: what is its molecular basis?

21 April 2017

1 reference

7 January 2021

Signaling vascular morphogenesis and maintenance

1 reference

7 January 2021

Vasculogenesis, angiogenesis, and growth factors: ephrins enter the fray at the border

1 reference

7 January 2021

A requirement for Flk1 in primitive and definitive hematopoiesis and vasculogenesis

1 reference

7 January 2021

Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo

1 reference

7 January 2021

The receptor tyrosine kinase TIE is required for integrity and survival of vascular endothelial cells.

1 reference

7 January 2021

Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation

1 reference

7 January 2021

Identifiers

DOI

10.1038/73550

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017